Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.

Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.

Item
http://www.wikidata.org/entity/Q36693199
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitusTreating the elderly diabetic patient: special considerationsSaxagliptinThe incretin system and cardiometabolic diseaseXenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism.The DPP-4 inhibitor linagliptin does not prolong the QT interval at therapeutic and supratherapeutic doses.Differential HbA1c response in the placebo arm of DPP-4 inhibitor clinical trials conducted in China compared to other countries: a systematic review and meta-analysis.Third-line agent selection for patients with type 2 diabetes mellitus uncontrolled with sulfonylureas and metformin.Sitagliptin: a review of its use in the management of type 2 diabetes mellitus.The Effect of Sitagliptin on Lipid Metabolism of Fatty Liver Mice and Related Mechanisms.Sitagliptin: a review of its use in patients with type 2 diabetes mellitus.The cardiometabolic benefits of glycine: Is glycine an 'antidote' to dietary fructose?Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes.Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes.Medical information about diabetes--how to keep up to date.Safety and Efficacy of DPP4 Inhibitor and Basal Insulin in Type 2 Diabetes: An Updated Review and Challenging Clinical Scenarios
P2860

Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.

Item
http://www.wikidata.org/entity/Q36693199
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Rationale for dipeptidyl pepti ...... t of type 2 diabetes mellitus.
@ast
Rationale for dipeptidyl pepti ...... t of type 2 diabetes mellitus.
@en
type
label
Rationale for dipeptidyl pepti ...... t of type 2 diabetes mellitus.
@ast
Rationale for dipeptidyl pepti ...... t of type 2 diabetes mellitus.
@en
prefLabel
Rationale for dipeptidyl pepti ...... t of type 2 diabetes mellitus.
@ast
Rationale for dipeptidyl pepti ...... t of type 2 diabetes mellitus.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Rationale for dipeptidyl pepti ...... t of type 2 diabetes mellitus.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921